, Institut national de la statistique et des études économiques. Population par âge. Février, 2018.
Aging and Multimorbidity : New Tasks, Priorities, and Frontiers for Integrated Gerontological and Clinical Research, J Am Med Dir Assoc, vol.16, p.640, 2015. ,
Multimorbidity in older adults, Epidemiol Rev, vol.35, pp.75-83, 2013. ,
Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many, Drug Saf, vol.39, pp.109-125, 2016. ,
Adverse drug reactions in an elderly hospitalised population, Drugs Aging, vol.22, pp.767-77, 2005. ,
The Association of Inappropriate Drug Use with Hospitalisation and Mortality. A Population& Based Study of the Very Old, Drugs Aging, vol.22, pp.69-82, 2005. ,
The Epidemiology of Serious Adverse Drug Reactions Among the Elderly, Drugs Aging, vol.14, pp.141-152, 1999. ,
Adverse drug reactions in elderly patients ,
, Br J Clin Pharmacol, vol.57, pp.121-126, 2003.
Is inappropriate médication use a major cause of adverse drug reactions in the elderly ?, Br J Clin Pharmacol, vol.63, pp.177-186, 2007. ,
Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist, Drugs Aging, vol.20, pp.817-849, 2003. ,
Consommation médicamenteuse chez le sujet âgé : consommation, prescription, iatrogénie et observance, 2005. ,
, Enquêtes Nationales sur les Evénements Indésirables graves associés aux Soins (ENEIS), 2009.
, Updated AGS Beers Criteria® for Potentially InappropriateMedication Use in Older Adults, American Geriatrics Society. American Geriatrics Society, vol.67, pp.674-694, 2019.
Potentially inappropriate medications in the elderly: a French consensus panel list, Eur J Clin Pharmacol, vol.63, pp.725-756, 2007. ,
Les critères STOPP/START v2 : adaptation en langue française, NPG Neurologie-Psychiatrie-Gériatrie, vol.15, pp.323-326, 2015. ,
Prevalence of Potentially Inappropriate Medication Use in Elderly Patients. Comparison between General Medical and Geriatric Wards, Drugs Aging, vol.23, pp.823-837, 2006. ,
Analyse qualitative à partir des ordonnances de 200 patients entrant dans un service de court séjour gériatrique. La revue de médecine interne, vol.33, pp.122-149, 2012. ,
Consommations et prescriptions pharmaceutiques chez les personnes âgées, Gérontologie et société, vol.4, pp.13-27, 2002. ,
, Rapport mondial sur le vieillissement et la santé, 2016.
, Consommation médicamenteuse chez le Sujet Agé, Haute Autorité de Santé (Legrain S), 2005.
Prendre en charge une personne âgée polypathologique en soins primaires, 2015. ,
, Organisation Mondiale de la Santé. Ma ladie chronique, 2016.
, , 1440.
Enquête sur la santé et la protection sociale en 2010. Les rapports de l'IRDES, 2012. ,
, A glossary of terms for community health care and services for older persons, Aging and Health Technical Report, 2004.
The Influence of Educational Level on Polypharmacy and Inappropriate Drug Use: A Register-Based Study of More Than 600,000 Older People, J Am Geriatr Soc, vol.57, pp.62-69, 2009. ,
Polypharmacy in primary care practices: an analysis using a large health insurance database, Pharmacoepidemiol Drug Saf, vol.18, pp.1206-1213, 2009. ,
Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems, Br J Clin Pharmacol, vol.63, pp.187-195, 2007. ,
Dispensed drugs and multiple medications in the Swedish population: an individual-based register study, BMC Clin Pharmacol, p.11, 2009. ,
polymédication : définitions, mesures et enjeux Revue de la littérature et tests de mesure Questions d'économie de la santé n° 204, 2014. ,
Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France, Eur J Clin Pharmacol, vol.73, pp.601-608, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01802839
Predicting and preventing adverse drug reactions in the very old, Drugd aging, vol.22, pp.375-392, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01335822
Médicaments potentiellement inappropriés aux personnes âgées : intérêt d'une liste adaptée à la pratique médicale française. La Revue de médecine interne, pp.592-601, 2009. ,
Patients Aged 80 Years or Older are Encountered More Potentially Inappropriate Medication Use, Chin Med J, vol.129, pp.22-27, 2016. ,
STOPP-START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people ,
, Can J Public Health, vol.100, pp.426-431, 2009.
Prescription Médicamenteuse chez le Sujet Agé (PMSA) -Programme Pilote, 2006. ,
, , 2007.
, , 2010.
La politique du médicament en EHPAD, 2013. ,
, Ministère des Solidarités et de la Santé. Le dispositif PAERPA, 2017.
Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review, BMJ Open, vol.5, p.9235, 2015. ,
Impact of medication reconciliation and review on clinical outcomes, Ann Pharmacother, vol.48, pp.1298-1312, 2014. ,
Interventions to improve the appropriate use of polypharmacy for older people, Cochrane Database Syst Rev, p.8165, 2014. ,
Prescrire chez le sujet âgé (plus de 75 ans ou plus de 65 ans et polypathologique) ,
Appropriate prescribing in elderly people: how well can it be measured and optimised ? The Lancet, vol.370, pp.173-184, 2007. ,
Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine, Arch Intern Med, vol.151, pp.1825-1832, 1991. ,
, Beers MH Explicit criteria for determining potentially inappropriate medication use by the elderly. An update, Arch Intern Med, vol.157, pp.1531-1536, 1997.
Updating the Beers criteria for potentially inappropriate medication use in older adults : results of a US consensus panel of experts, Arch Intern Med, vol.163, pp.2716-2724, 2003. ,
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults, J Am Geriatr Soc, vol.60, pp.616-631, 2012. ,
Look at the 2015 Beers Criteria, J Pharm Pract, vol.30, pp.419-424, 2017. ,
Defining inappropriate practices in prescribing for elderly people: a national consensus panel, Can Med Assoc J, vol.156, pp.385-391, 1997. ,
Development and validation of an improving prescribing in the elderly tool Can, J Clin Pharmacol, vol.7, pp.103-107, 2000. ,
Potentially inappropriate medication use in the community-dwelling elderly, 1996. ,
, Medical Expenditure Panel Survey. J Am Med Ass, vol.286, pp.2823-2832, 2001.
The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study, Scand J Pirm Health Care, vol.27, pp.153-159, 2009. ,
Beyond the Beers criteria: a comparative overview of explicit criteria, Ann Pharmacother, vol.44, pp.1968-1975, 2010. ,
Selection of tools for reconciliation, compliance and appropriateness of treatment in patients with multiple chronic conditions, Eur J Intern Med, vol.23, pp.506-512, 2012. ,
Detection of inappropriate medication use in the elderly; will the STOPP and START criteria become the new Dutch standards, Ned Tijdschr Geneeskd, vol.156, p.5076, 2012. ,
, Agence Nationale du Médicament et des Produits de Santé. Bon usage des agents antiplaquettaires, 2012.
CVD Prevention in Clinical Practice (European Guidelines on, 2017. ,
, Guideline on the Primary Prevention of Cardiovascular Disease, American College of Cardiology/American Heart Association, 2019.
,
Aspirin overprescription in primary cardiovascular prevention, Thromb Res, vol.118, pp.471-477, 2006. ,
Aspirin misuse at home according to the START and STOPP in frail older persons, European Geriatric Medicine, 2012. ,
Analyse qualitative à partir des ordonnances de200 patients entrant dans un service de court séjour gériatrique. La revue de médecine interne, vol.33, pp.122-149, 2012. ,
Grandes fréquences des prescriptions médicamenteuses à visée cardiovasculaire potentiellement inappropriées dans la population âgée. La Presse Médicale, 2015. ,
Frequency and practicelevel variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry, J Am Coll Cardiol, vol.65, pp.111-121, 2015. ,
, ESC Clinical Practice Guidelines. Management of atrial fibrillation, 2016.
Analyse des ventes de médicaments en France en 2013, 2014. ,